External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

EAU 2022

-
Coming soon
07:45 AM
Duration 15mins Orange Area, eURO Auditorium 1
Overall Survival by Circulating Tumor DNA Status in Patients With Post-operative Muscle-invasive Urothelial Carcinoma Treated With Atezolizumab: Update From IMvigor010
Gschwend J, Assaf Z, Mariathasan S, Hussain M, Oudard S, Albers P, Castellano D, Nishiyama H, Daneshmand S, Grivas P, Sharma S, Sethi H, Aleshin A, Degaonkar V, Shi Y, Davarpanah N, Carter C, Bellmunt J, Powles T

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar